ProMIS Neurosciences Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

ProMIS Neurosciences Stock Summary

ProMIS Neurosciences competes with Zenith Capital, Fennec Pharmaceuticals, Gain Therapeutics, Biovie, and In8bio. ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimers disease , amyotrophic lateral sclerosis , and multiple system atrophy in Canada. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada. Promis Neurosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 5 people.

ProMIS Neurosciences Key Financial Ratios

ProMIS Neurosciences Key Balance Sheet Accounts

ProMIS Neurosciences Key Cash Accounts

ProMIS Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining ProMIS Neurosciences's current stock value. Our valuation model uses many indicators to compare ProMIS Neurosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ProMIS Neurosciences competition to find correlations between indicators driving ProMIS Neurosciences's intrinsic value. More Info.ProMIS Neurosciences is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, ProMIS Neurosciences' Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ProMIS Neurosciences' earnings, one of the primary drivers of an investment's value.

ProMIS Neurosciences Systematic Risk

Today, most investors in ProMIS Neurosciences Stock are looking for potential investment opportunities by analyzing not only static indicators but also various ProMIS Neurosciences' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of ProMIS Neurosciences growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of ProMIS Neurosciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of ProMIS Neurosciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of ProMIS Neurosciences based on widely used predictive technical indicators. In general, we focus on analyzing ProMIS Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build ProMIS Neurosciences's daily price indicators and compare them against related drivers.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ProMIS Neurosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. To learn how to invest in ProMIS Stock, please use our How to Invest in ProMIS Neurosciences guide.You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProMIS Neurosciences. If investors know ProMIS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProMIS Neurosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of ProMIS Neurosciences is measured differently than its book value, which is the value of ProMIS that is recorded on the company's balance sheet. Investors also form their own opinion of ProMIS Neurosciences' value that differs from its market value or its book value, called intrinsic value, which is ProMIS Neurosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProMIS Neurosciences' market value can be influenced by many factors that don't directly affect ProMIS Neurosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between ProMIS Neurosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if ProMIS Neurosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProMIS Neurosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.